Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 14:23:1773-1785.
doi: 10.1016/j.csbj.2024.04.033. eCollection 2024 Dec.

Gene regulatory network analysis identifies MYL1, MDH2, GLS, and TRIM28 as the principal proteins in the response of mesenchymal stem cells to Mg2+ ions

Affiliations

Gene regulatory network analysis identifies MYL1, MDH2, GLS, and TRIM28 as the principal proteins in the response of mesenchymal stem cells to Mg2+ ions

Jalil Nourisa et al. Comput Struct Biotechnol J. .

Abstract

Magnesium (Mg)-based implants have emerged as a promising alternative for orthopedic applications, owing to their bioactive properties and biodegradability. As the implants degrade, Mg2+ ions are released, influencing all surrounding cell types, especially mesenchymal stem cells (MSCs). MSCs are vital for bone tissue regeneration, therefore, it is essential to understand their molecular response to Mg2+ ions in order to maximize the potential of Mg-based biomaterials. In this study, we conducted a gene regulatory network (GRN) analysis to examine the molecular responses of MSCs to Mg2+ ions. We used time-series proteomics data collected at 11 time points across a 21-day period for the GRN construction. We studied the impact of Mg2+ ions on the resulting networks and identified the key proteins and protein interactions affected by the application of Mg2+ ions. Our analysis highlights MYL1, MDH2, GLS, and TRIM28 as the primary targets of Mg2+ ions in the response of MSCs during 1-21 days phase. Our results also identify MDH2-MYL1, MDH2-RPS26, TRIM28-AK1, TRIM28-SOD2, and GLS-AK1 as the critical protein relationships affected by Mg2+ ions. By offering a comprehensive understanding of the regulatory role of Mg2+ ions on MSCs, our study contributes valuable insights into the molecular response of MSCs to Mg-based materials, thereby facilitating the development of innovative therapeutic strategies for orthopedic applications.

Keywords: Gene regulatory network analysis; Magnesium ions; Mesenchymal stem cells; Proteomics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

ga1
Graphical abstract
Fig. 1
Fig. 1
The overview of the methodology implemented in this study. (A) Proteomics data were collected for the control and treatment groups, where the treatment group was exposed to 5 mM of Mg2+ ions. (B) The proteomics data were normalized to remove potential biases, and missing values were imputed using two the methods of KNN and MinProb. (C) Time-series analysis was performed to identify the most sensitive proteins to Mg2+ ions. (D) Network analysis was performed to reveal protein regulatory connections. (E) Model selection was employed to choose the best-performing GRN model according to the known links provided by the STRING database. (F) Protein role analysis was employed to obtain the proteins’ regulatory roles and to determine the proteins with a significant role change in response to Mg2+ ions. (G) Protein regulatory divergence analysis was performed to detect the regulatory links most affected by Mg2+ ions. Target proteins were identified using the cumulative information of F and G.
Fig. 2
Fig. 2
The protocol of GRN inference using regression analysis. Time-series data (A) was discretized to obtain learning samples of Fi (B). Next, the data was partitioned into sets of features and targets for each protein (C). Then, n regression models were trained using the expression data of n proteins in the network using RF and Ridge models (D).
Fig. 3
Fig. 3
(A) The distribution of the missingness across different samples and measurement days. (B) The count of the DE proteins identified for different datasets and their interactions. Gene names are used instead of protein names. (C) Prediction scores of the protein expression for the regression-based models of RF and Ridge. Those models indicated as ✓ outperform the baseline random models (red dashed line). (D) The performance of different models in recovering the known links, measured by EPR score. The baseline models represent the scores obtained for the 1000 randomly generated networks. The numbers in percentage indicate the percentile rank of each model compared to the random models. The models chosen for short- and long-term responses are distinguished by their names encircled in a red oval. (E) The performance of the selected models of ShortTerm-MinProb-Portia and LongTerm-KNN-Portia compared to 100 models built using randomly chosen proteins as regulators. Red asterisks (*) represent the top 5% percentile ranks.
Fig. 4
Fig. 4
The results of the protein role analysis for the selected model of (A) the short-term and (B) the long-term response. The dashed lines in the plots indicate the upper 75th percentile on each axes. Column (3) shows the significant protein role change across control and Mg2+ ions treatment. Gene names are used instead of protein names.
Fig. 5
Fig. 5
The significance of divergence in the regulatory links due to Mg2+ ion treatment is given in the first column, A-a and B-a. The color of the edges shows the significance of the change from control to Mg2+ ions treatment. The active sum shows the regulatory influence of a protein on the rest of the network. The regulatory effect shows the strength of the regulation. These two complementary indications are only for the second column (A-b and B-b). Gene names are used instead of protein names. The graph was created using Cytoscape .

Similar articles

Cited by

References

    1. Willumeit-Römer R. The interface between degradable mg and tissue. Jom. 2019;vol. 71(4):1447–1455. doi: 10.1007/s11837-019-03368-0. - DOI
    1. Agha N.A., Willumeit-Römer R., Laipple D., Luthringer B., Feyerabend F. The degradation interface of magnesium based alloys in direct contact with human primary osteoblast cells. PLoS One. 2016;vol. 11(6):1–20. doi: 10.1371/journal.pone.0157874. - DOI - PMC - PubMed
    1. Einhorn T.A. The cell and molecular biology of fracture healing. Clin Orthop Relat Res. 1998;vol. 355S:S7–S21. doi: 10.1097/00003086-199810001-00003. - DOI - PubMed
    1. Qiao W., et al. TRPM7 kinase-mediated immunomodulation in macrophage plays a central role in magnesium ion-induced bone regeneration. Nat Commun. 2021;vol. 12(2885) doi: 10.1038/s41467-021-23005-2. - DOI - PMC - PubMed
    1. Croes M., et al. Proinflammatory mediators enhance the osteogenesis of human mesenchymal stem cells after lineage commitment. PLoS One. 2015;vol. 10(7):1–14. doi: 10.1371/journal.pone.0132781. - DOI - PMC - PubMed